3 Papers
1 Citations
Li Yu is an academic researcher from Weifang Medical University. The author has contributed to research in topics: Chemistry & Reperfusion injury. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
Protective role of N-acetyl-l-tryptophan against hepatic ischemia-reperfusion injury via the RIP2/caspase-1/IL-1β signaling pathway.
Jianxin Wang,Shuna Yu,Jianguo Li,Huiting Li,Hongxin Jiang,Peilun Xiao,Yitong Pan,Jie Zheng,Li Yu,Jiying Jiang +9 more
TL;DR: It is indicated that l- NAT may exert a hepatoprotective role in HIRI through inhibiting RIP2/caspase-1/IL-1β signaling pathway, which can provide evidence for l-NAT to be a potential effective drug against HIRi during clinical practice.
23
[Air fine particulate matter induced alveolar type Ⅱ epithelial cell injury in rats].
Hongyang Ke,Chuan Ouyang,Jiali Zhao,Xuan Ma,Yumei Liu,Liwen Zhang,Xiaohong Li,Jinfeng Tan,Li Yu,Wanwei Li +9 more
TL;DR: In this paper , the damage of rat alveolar type II epithelial cells (RLE-6 TN) caused by air fine particulate matter (PM_(2.5)) and its related mechanism was investigated.
2
Protective role of N-acetyl-L-tryptophan against hepatic ischemia-reperfusion injury by the TLR4/NF-ΚB signaling pathway
Jianxin Wang,Shuna Yu,Huiting Li,Hongxin Jiang,Peilun Xiao,Yitong Pan,Zhe Wang,Jie Zheng,Li Yu,Jiying Jiang +9 more
- 10 Jan 2019
TL;DR: In this paper, the authors investigated whether Nacetyl-L-tryptophan (L-NAT) could protect hepatocytes against acute hepatic ischemia-reperfusion injury through the TLR4/NF-κB signaling pathway and its possible mechanisms.
1